FLASCO / Sponsorship Levels Platinum

CTI Biopharma

FLASCO
July 20, 2022
No Comments

Name Location Phone Email Amy Henderson, KAM Panhandle 205-215-1926 [email protected] Tom Rice, KAM Jacksonville 603-625-2022 [email protected] Dawn Waldorf, KAM Orlando 386-334-3390 [email protected] Diana Otero, KAM Miami 786-346-4282 [email protected] Rob Blair, KAM Fort Myers 239-281-8278 [email protected] Sarah Trimpe, KAM Tampa 813-731-0981 [email protected] Tiffany Bourne, MSL Southeast 678-895-9621 [email protected] Misty Braun, RBD Southeast 239-293-9601 [email protected] KAM:…

PharmaEssentia^TM

FLASCO
July 6, 2022
No Comments

PharmaEssentia Corporation, based in Taipei, Taiwan, is a rapidly growing biopharmaceutical innovator. Leveraging deep expertise and proven scientific principles, the company aims to deliver effective new biologics for challenging diseases in the areas of hematology and oncology, with one approved product and a diversifying pipeline. Founded in 2003 by a team of Taiwanese-American executives and…

MacroGenics, Inc

FLASCO
January 10, 2022
No Comments

MacroGenics is a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer. The Company’s flagship product for the treatment of HER2+ metastatic breast cancer was approved by the US Food and Drug Administration in December 2020. MacroGenics generates its pipeline of product candidates primarily from its proprietary suite…

ADC Therapeutics

FLASCO
July 13, 2021
No Comments

ADC Therapeutics. Confronting cancer with the full potential of our science. ADC Therapeutics is a commercial-stage biotechnology company improving the lives of cancer patients with its next-generation, targeted antibody drug conjugates (ADCs. ADC Therapeutics is advancing its proprietary PBD-based ADC technology to transform the treatment paradigm for patients with hematologic malignancies and solid tumors. Visit…

Regeneron

FLASCO
March 25, 2021
No Comments

GRAIL

Katrina Williams
February 8, 2021
No Comments

Deciphera Pharmaceuticals

Katrina Williams
May 20, 2020
No Comments

Deciphera is a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer. We are leveraging our proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology to develop a broad portfolio of innovative medicines. In addition to advancing multiple product candidates from our platform…

Karyopharm Therapeutics

FLASCO
April 10, 2020
No Comments

Karyopharm Therapeutics Inc. is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of novel first-in-class drugs directed against nuclear export and related targets for the treatment of cancer and other major diseases. Karyopharm’s Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and inhibiting the…

Daiichi Sankyo, Inc.

FLASCO
March 19, 2020
No Comments

Daiichi Sankyo is dedicated to creating new modalities and innovative medicines by leveraging our world-class science and technology for our purpose “to contribute to the enrichment of quality of life around the world.” In addition to our current portfolio of medicines for cancer and cardiovascular disease, Daiichi Sankyo is primarily focused on developing novel therapies…

Natera

Katrina Williams
September 4, 2019
No Comments

Natera has developed Signatera, a personalized ctDNA test for molecular residual disease (MRD) detection and recurrence monitoring in patients previously diagnosed with cancer. Signatera’s tumor-informed assay is optimized to detect low levels of ctDNA, with high accuracy in identifying MRD and recurrence with longer lead times. Signatera has been clinically validated in multiple cancer types…

Coherus Biosciences

Katrina Williams
February 6, 2019
No Comments

Coherus is led by a team of biotech industry pioneers focused on disrupting the status-quo and driving tangible change in healthcare. Many of our leaders were directly involved in developing, manufacturing, and commercializing blockbuster biologics that elevated biologics from niche to mainstream medicine. Today, the team is unlocking the true potential of this category and…

Servier Pharmaceuticals

FLASCO
September 12, 2018
No Comments

Servier Pharmaceuticals is a commercial-stage pharmaceuticals company with a passion for innovation and improving the lives of patients, their families and caregivers. In the United States, Servier Pharmaceuticals is committed to building a robust portfolio, starting with oncology, with future growth driven by innovation in other areas of unmet medical need, leveraging Servier’s global portfolio…

EMD Serono

FLASCO
March 22, 2017
No Comments

At EMD Serono, the healthcare business sector of Merck KGaA, Darmstadt, Germany, in the US and Canada, our scientific approach in oncology focuses on oncogenic pathways, immuno-oncology, and DNA damage response. To deliver breakthrough cancer therapies, we complement our internal expertise and development programs with scientific collaborations to improve trial designs, accelerate treatment development, and…

Adaptive Biotechnologies®

FLASCO
March 16, 2017
No Comments

Adaptive Biotechnologies Company Description Adaptive Biotechnologies is a commercial-stage biotechnology company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. We believe the adaptive immune system is nature’s most finely tuned diagnostic and therapeutic for most diseases, but the inability to decode it has prevented the…

Exelixis, Inc.

FLASCO
June 7, 2016
No Comments

Founded in 1994, Exelixis is a biotechnology company that strives to accelerate the discovery, development and commercialization of new medicines. Visit our website to learn more. https://www.exelixis.com.

Pharmacyclics

FLASCO
July 16, 2015
No Comments

For more information about Pharmacyclics LLC, an AbbVie Company, please visit pharmacyclics.com.

Novartis

FLASCO
July 16, 2015
No Comments

Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products…

Sandoz, a Novartis Division

FLASCO
July 16, 2015
No Comments

Sandoz, a Novartis division, is a global leader in generic pharmaceuticals and biosimilars. Our purpose is to pioneer access for patients by developing and commercializing novel, affordable approaches that address unmet medical need. With our leading-edge processes in manufacturing, strong pipeline of treatments and reliable supply, we strive to improve patient access to more affordable,…

EISAI

May 8, 2015
No Comments

Taiho Oncology

April 26, 2015
No Comments

Taiho Oncology, Inc., a division of Taiho Pharmaceutical Co., Ltd. and Otsuka Holdings Co., Ltd., has built a world class clinical development organization that works urgently to develop innovative cancer treatments. Taiho has an oral oncology pipeline consisting of both novel antimetabolic agents and selectively targeted agents. Advanced technology, dedicated researchers, and state of the…

Biodesix

FLASCO
February 12, 2015
No Comments

Biodesix was founded in 2005 to apply the principles of complex data analysis and mass spectrometry (MS) to the discovery and development of improved multivariate tests that give physicians better information to understand the patient and their disease. Understanding the clinically meaningful information contained within each patient’s molecular profile may improve diagnosis and therapeutic intervention…

Janssen Oncology, Pharmaceutical Companies of Johnson & Johnson

FLASCO
February 9, 2015
No Comments

For more than 30 years, Janssen Biotech, Inc. has delivered on the promise of new treatments and ways to improve the health of individuals with serious disease. Built upon a rich legacy of innovative firsts, Janssen Biotech, Inc. pursues innovative solutions in the therapeutic areas of immunology, oncology, urology and nephrology. With the same unwavering…